Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care
Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04978389
Collaborator
(none)
10
1
3.6
2.8
Study Details
Study Description
Brief Summary
Inter-observer reproductibility of visual estimation of left ventricular ejection fraction is known to be good in cardiology but has not been studied in ICU. The goal of the study is to determine if this reproductibility is good enough.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
10 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care
Actual Study Start Date
:
Sep 1, 2021
Actual Primary Completion Date
:
Dec 1, 2021
Actual Study Completion Date
:
Dec 20, 2021
Outcome Measures
Primary Outcome Measures
- reproductibility of LVEF in percentage [day 1]
reproductibility of LVEF in percentage
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
-
practitioners working in intensive care.
-
age > 18 years
Exclusion criteria:
- Age under 18
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Uhmontpellier | Montpellier | France | 34295 |
Sponsors and Collaborators
- University Hospital, Montpellier
Investigators
- Study Director: Kada KLOUCHE, MD PhD, UH Montpellier
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04978389
Other Study ID Numbers:
- RECHMPL21_0462
First Posted:
Jul 27, 2021
Last Update Posted:
Feb 2, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No